StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.39+0.02 (+5.58%)

Close on Nov 16, 2026Market cap $3.41MP/E 0.4Yield –

Evogene operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$13.50M. The highest annual figure on record is -$11.69M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.50M–
FY2024Dec 31, 2024-$19.70M–
FY2023Dec 31, 2023-$21.58M–
FY2022Dec 31, 2022-$23.68M–
FY2021Dec 31, 2021-$24.72M–
FY2020Dec 31, 2020-$19.51M–
FY2019Dec 31, 2019-$17.67M–
FY2018Dec 31, 2018-$15.16M–
FY2017Dec 31, 2017-$15.93M–
FY2016Dec 31, 2016-$11.69M–
FY2015Dec 31, 2015-$12.41M–

More Evogene figures

See a number that looks wrong?